Content about Morphinans

October 24, 2010
Pharmacy crime discussed at NCPA conference

Community pharmacists got a briefing about pharmacy security from a company that has learned a...

October 18, 2010
Purdue Pharma supports state Rx monitoring programs

Drug maker Purdue Pharma has donated $200,000 to the National Association of State Controlled Substances...

October 10, 2010
Industry anxiously awaiting FDA decision on DXM’s fate

While the fact that two Food and Drug Administration advisory committees collectively voted 15 opposed...

October 6, 2010
CADCA, CHPA kick off annual National Medicine Abuse Awareness Month

The Community Anti-Drug Coalitions of America and the Consumer Healthcare Products Association on Wednesday joined...

October 6, 2010
Watson, Endo settle Opana ER patent suit

Watson Pharmaceuticals has settled a patent lawsuit with Endo Pharmaceuticals concerning an Endo prescription painkiller,...

September 21, 2010
FDA grants priority review for crush-resistant, long-acting oxymorphone

The Food and Drug Administration has granted priority review to an opioid painkiller designed to...

September 16, 2010
FDA should consult advisory committees on DXM issue

While the advisory committee vote of 15 opposed and nine in favor of scheduling the...

September 14, 2010
FDA advisory committees forgo restricting cough-cold sales, CHPA responds

A pair of Food and Drug Administration advisory committees on Tuesday evening recommended that the...

September 13, 2010
NACDS to FDA advisory committee: Curb DXM abuse without impeding appropriate use

As the Food and Drug Administration's Drug Safety and Risk Management Committee debated Tuesday on...

September 9, 2010
CMPI survey: Alcohol, marijuana biggest substance problems among teens

The Center for Medicine in the Public Interest on Thursday released the results of a...

August 31, 2010
FDA to discuss concerns over medicines with DXM

The Food and Drug Administration last week issued an information packet in preparation for a...

August 8, 2010
Endo to acquire Penwest for $168 million

Endo Pharmaceuticals will acquire Penwest Pharmaceuticals for $168 million, Penwest said Monday....

July 18, 2010
J&J: Nucynta produced fewer side effects than competitor in trial

A Johnson & Johnson pain drug produced fewer side effects in patients than oxycodone, according...

June 7, 2010
Endo, Penwest grant Opana ER license to Impax

Endo Pharmaceuticals and Penwest Pharmaceuticals will grant Impax Labs a special license to sell a...

June 6, 2010
FDA re-evaluates DXM abuse potential; pharmacy retailers, groups respond

The Food and Drug Administration will be re-evaluating the abuse potential of the cough-cold ingredient...

May 23, 2010
Decision Resources report: Nucynta as effective as immediate-release oxycodone

Most surveyed physicians who have prescribed a dual-acting opioid painkiller made by Johnson & Johnson...

May 16, 2010
Impax receives tentative approval for generic Opana ER

The Food and Drug Administration has given tentative approval to an Impax Labs drug for...

May 3, 2010
FDA advisory committee to discuss curbing DXM abuse

The Food and Drug Administration on Tuesday announced through the Federal Register that a Sept....

March 8, 2010
Watson seeks approval for generic Opana

Watson Pharmaceuticals has filed a regulatory approval application for a generic version of a painkiller...

March 2, 2010
New survey finds teens lack negative perceptions about many drugs

While there was no significant increase in the abuse of over-the-counter cough medicines containing dextromethorphan,...

September 27, 2009
CHPA, CADCA commend OTC cough medicine abuse legislation

The greater awareness raised around the potential of abuse of drugs commonly stored in the...

© 2013 Drug Store News. All Rights Reserved.